Literature DB >> 25441987

Monitoring of prostate cancer growth and metastasis using a PSA luciferase report plasmid in a mouse model.

Qi-Qi Mao1, Yi-Wei Lin1, Hong Chen1, Kai Yang1, De-Bo Kong1, Hai Jiang2.   

Abstract

OBJECTIVE: To construct a PSA luciferase report plasmid and monitor the growth and metastasis of prostate cancer after emasculation in SCID mice.
METHODS: PSA promoter sequence and luciferase gene were amplified by PCR and subsequently inserted into pZsGreen1-1 vector to construct pPSA-FL-Luc vector. LNCaP cells that were stably transfected with pPSA-FL-Luc were used to establish a SCID mouse xenograft model. Then, the growth and metastasis of prostate cancer were monitored via living imaging.
RESULTS: We successfully constructed a PSA luciferase plasmid, pPSA-FL-Luc. DHT enhanced luciferase activity in a concentration-dependent manner in 293T cells with pPSA-FL-Luc transfection. Prostate cancer SCID mouse model was established with pPSA-FL-Luc transfected LNCaP cells. In tumor bearing mice with or without emasculation, pPSA-FL-Luc plasmid was applied to monitored tumor growth and metastasis based on bioluminescence imaging.
CONCLUSIONS: We construct a pPSA-FL-Luc plasmid, which stably expresses luciferase and can be applied to monitor tumor development in a prostate SCID mouse model.
Copyright © 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Luciferase report gene; Metastasis; Prostate cancer; tumor growth

Year:  2014        PMID: 25441987     DOI: 10.1016/S1995-7645(14)60153-X

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  2 in total

1.  Targeting miR-21 with AS-miR-21 suppresses aggressive growth of human tongue squamous cell carcinoma in vivo.

Authors:  Yin Wang; Yu Zhu; Pin Lv; Longjiang Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 2.  Investigation of the Anti-Prostate Cancer Properties of Marine-Derived Compounds.

Authors:  Meiqi Fan; Amit Kumar Nath; Yujiao Tang; Young-Jin Choi; Trishna Debnath; Eun-Ju Choi; Eun-Kyung Kim
Journal:  Mar Drugs       Date:  2018-05-12       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.